Delta-Fly Pharma

Delta-Fly Pharma EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Delta-Fly Pharma (4598.T) as of Oct 22, 2026 is -1.61 B JPY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -1.71 B JPY — a change of -5.99% (higher).

EBITDA

-1.61 BJPY

YoY

-5.99%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Delta-Fly Pharma is 2026 -1.61 B JPY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Delta-Fly Pharma was 2025 -1.71 B JPY. It decreases by -5.99% higher compared to the previous year.

The Delta-Fly Pharma EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
-592.52 M JPY
Jan 1, 2020
-1.55 B JPY
Jan 1, 2021
-855.45 M JPY
Jan 1, 2022
-962.26 M JPY
Jan 1, 2023
-1.32 B JPY
Jan 1, 2024
-1.41 B JPY
Jan 1, 2025
-1.71 B JPY
Jan 1, 2026
-1.61 B JPY
The Delta-Fly Pharma EBITDA history
YEAREBITDAYoY
-1.61 BJPY-5.99%
-1.71 BJPY+21.22%
-1.41 BJPY+6.63%
-1.32 BJPY+37.34%
-962.26 MJPY+12.49%
-855.45 MJPY-44.65%
-1.55 BJPY+160.84%
-592.52 MJPY+142.55%
-244.29 MJPY-174.33%
328.66 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Delta-Fly Pharma Stock analysis

What does Delta-Fly Pharma do? Delta-Fly Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Delta-Fly Pharma stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Delta-Fly Pharma is -1.61 B JPY in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Delta-Fly Pharma changed from -1.71 B JPY to -1.61 B JPY, representing a -5.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Delta-Fly Pharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Delta-Fly Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Delta-Fly Pharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Delta-Fly Pharma